Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

This study has been terminated.
(Closed due to insufficient recruitment.)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00234442
First received: October 5, 2005
Last updated: June 29, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given